FDA Approved: EVOTAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

View source ↗

Summary

FDA approved a supplemental application for EVOTAZ (atazanavir and cobicistat) to update the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• EVOTAZ (atazanavir and cobicistat)

Snippet

SUPPL AP for EVOTAZ (ATAZANAVIR AND COBICISTAT)